HCID 67034022, compound → HCID 67034597, compound

Participants

Reaction Steps

(3aS,7aR)-3-(3-(3-fluoro-4-(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-1,2,4-triazol-5-yl)phenyl)pyrazolo[1,5-a]pyrimidin-5-yl)hexahydrobenzo[d]oxazol-2(3H)-one (17 mg, 52%) was prepared by the procedure described in Example 1, Step 8, using (3aS,7aR)-3-(3-bromopyrazolo[1,5-a]pyrimidin-5-yl)hexahydrobenzo[d]oxazol-2(3H)-one and 5-(2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-1,2,4-triazole.

Provenance & Evidence